579 related articles for article (PubMed ID: 26237041)
1. MECP2 disorders: from the clinic to mice and back.
Lombardi LM; Baker SA; Zoghbi HY
J Clin Invest; 2015 Aug; 125(8):2914-23. PubMed ID: 26237041
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
4. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
Pohodich AE; Zoghbi HY
Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
6. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
[TBL] [Abstract][Full Text] [Related]
7. The molecular pathology of Rett syndrome: synopsis and update.
Akbarian S; Jiang Y; Laforet G
Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
[TBL] [Abstract][Full Text] [Related]
8. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies.
Sandweiss AJ; Brandt VL; Zoghbi HY
Lancet Neurol; 2020 Aug; 19(8):689-698. PubMed ID: 32702338
[TBL] [Abstract][Full Text] [Related]
9. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.
Robinson L; Guy J; McKay L; Brockett E; Spike RC; Selfridge J; De Sousa D; Merusi C; Riedel G; Bird A; Cobb SR
Brain; 2012 Sep; 135(Pt 9):2699-710. PubMed ID: 22525157
[TBL] [Abstract][Full Text] [Related]
10. Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome.
Jiang M; Ash RT; Baker SA; Suter B; Ferguson A; Park J; Rudy J; Torsky SP; Chao HT; Zoghbi HY; Smirnakis SM
J Neurosci; 2013 Dec; 33(50):19518-33. PubMed ID: 24336718
[TBL] [Abstract][Full Text] [Related]
11. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides.
Sztainberg Y; Chen HM; Swann JW; Hao S; Tang B; Wu Z; Tang J; Wan YW; Liu Z; Rigo F; Zoghbi HY
Nature; 2015 Dec; 528(7580):123-6. PubMed ID: 26605526
[TBL] [Abstract][Full Text] [Related]
12. Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors.
Li W; Xu X; Pozzo-Miller L
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):E1575-84. PubMed ID: 26929363
[TBL] [Abstract][Full Text] [Related]
13. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
Heckman LD; Chahrour MH; Zoghbi HY
Elife; 2014 Jun; 3():. PubMed ID: 24970834
[TBL] [Abstract][Full Text] [Related]
14. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.
Ehrhart F; Coort SL; Cirillo E; Smeets E; Evelo CT; Curfs LM
Orphanet J Rare Dis; 2016 Nov; 11(1):158. PubMed ID: 27884167
[TBL] [Abstract][Full Text] [Related]
15. Neuronal non-CG methylation is an essential target for MeCP2 function.
Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
[TBL] [Abstract][Full Text] [Related]
16. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
[TBL] [Abstract][Full Text] [Related]
17. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
18. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]